Browse > Article

The impact of early detection through school urinary screening tests of membranoproliferative glomerulonephritis type I  

Chung, Sung-Hoon (Department of Pediatrics, College of Medicine, Kyunghee University)
Park, Sung-Sin (Department of Pediatrics, College of Medicine, Kyunghee University)
Kim, Sung-Do (Department of Pediatrics, College of Medicine, Kyunghee University)
Cho, Byoung-Soo (Department of Pediatrics, College of Medicine, Kyunghe)
Publication Information
Clinical and Experimental Pediatrics / v.50, no.11, 2007 , pp. 1104-1109 More about this Journal
Abstract
Purpose : Since 1998, school urinary screening tests have been performed on Korean school children. We could detect and treat so many asymptomatic chronic renal disease in early stage. We investigated the efficacy of school urinary screening tests from children with membranoproliferative glomerulonephritis (MPGN) type I. Methods : We analyzed the characteristics and prognosis of 18 patients with MPGN type I who admitted after 1996 and received steroid therapy with or without cyclosporine. These patients were divided into two groups. Group A (asymptomatic patients detected by school urinary screening tests) consisted of 7 patients; Group S (symptomatic patients) consisted 11 patients. Results : Mean follow-up duration was 6.3 years (from 2 to 11 years). Urinary protein excretion was 1.1 g/day in group A and 6.6 g/day in group S. 24 hour creatinine clearance (mL/min/$1.73m^2$) was 134.3 in group A and 82.3 in group S. No patients in group A had renal insufficiency, but three patients in group S had renal insufficiency and one patient required peritoneal dialysis. Conclusion : Early detection by school urinary screening tests improves prognosis of MPGN type I.
Keywords
School urinary screening tests; Membranoproliferative glomerulonephritis; 24 hour creatinine clearance; Renal insufficiency; Steroid therapy;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Arslan S, Saatci U, Ozen S, Bakkaloglu A, Besbas N, Tinaztepe K, et al. Membranoproliferative glomerulonephritis in childhood: Factors affecting prognosis. Int Urol Nephrol 1997:29:711-6   DOI   ScienceOn
2 Cho BS, Kim SD, Choi YM, Kang HH. School urinary screening in Korea: prevalence of chronic renal disease. Pediatr Nephrol 2001;16:1126-8   DOI
3 Ohsawa I, Ohi H, Endo M, Fujita T, Fukatsu A, Yamaguchi Y. Histological restoration in an adult with membranoproliferative glomerulonephritis. Clin Exp Nephrol 2000; 4:344-7   DOI
4 Yanagihara T, Hayakawa M, Yoshida J, Masami T, Morita T, Tsuchiya M, et al. Long-term follow-up of diffuse membranoproliferative glomerulonephritis type I. Pediatr Nephrol 2005;20:585-90   DOI
5 Tarshish P, Bernstein J, Tobin JN, Edelmann CM. Treatment of mesangiocapillary glomerulonephritis with alternateday prednisone-a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 1992;6:123-30   DOI
6 Jones G, Juszczak M, Kingdon E, Harber M, Sweny P, Burns A. Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids. Nephrol Dial Transplant 2004;19:3160-4   DOI   ScienceOn
7 Ito T, Hasegawa S, Sakaguchi H. Methylprednisolone pulse therapy for membranoproliferative glomerulonephritis. Jpn J Nephrol 1978;20:682-5
8 Levin A. Management of membranoproliferative glomerulonephritis: evidence-based recommendations. Kidney lnt Suppl 1999;55:S41-6   DOI   ScienceOn
9 Antonovych TT, Sabnis SG, Broumand BE. A study of membranoproliferative glomerulonephritis in Iran. Ann Saudi Med 1999;19:505-10   DOI
10 McEnergy PT, McAdams AJ, West CD. The effect of prednisone in a high-dose alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis. Medicine 1986;64:401-24
11 Donadio JV, Slack TK, Holley KE, Ilstrup DM. Idiopathic membranoproliferative (mesangiocapillary) glomerulonephritis: a clinicopathologic study. Mayo Clin Proc 1979;54:141-50
12 West CD, McAdams AJ, McCoville JM, Davis NC, Holland NH. Hypocomplementemic and normocomplementemic persistentrchronic) glomerulonephritis; clinical and pathologic characteristics. J Pediatr 1965;67:1089-112   DOI
13 Iitaka K, Nakamura S, Moriya S, Motoyama O, Sakai T. Focal segmental membranoproliferative glomerulonephritis in children. Pediatr Nephrol 2003;18:1000-4   DOI
14 Bergstein JM, Andreoli SP. Response of type I membraneproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy. Pediatr Nephrol 1995; 9:268-71   DOI
15 Belgiojoso B, Tarantino A, Colasanti G, Bazzi C, Guerra L, Durante A. The prognostic value of some clinical and histological parameters in membranoproliferative glomerulonephritis (MPGN): report of 112 cases. Nephron 1977;19:2508
16 Ford DM, Briscoe DM, Shanley PF, Lum GM. Childhood membranoproliferative glomerulonephritis type I : limited steroid therapy. Kidney lnt 1992;41:1606-12   DOI   ScienceOn
17 Somers M, Kertesz S, Rosen S, Herrin J. Colvin R, Palacios de Carreta N, et al. Non-nephrotic children with membranoproliferative glomerulonephritis: are steroids indicated? Pediatr Nephrol 1995;9:140-4   DOI
18 West CD. Idiopathic membranoproliferative glomerulonephritis in childhood. Pediatr Nephrol 1992;6:96-103   DOI
19 Iitaka K, Igarashi S, Sakai T. Hypocomplementaemia and membranoproliferative glomerulonephritis in school urinary screening in Japan. Pediatr Nephrol 1994;8:420-2   DOI
20 Kawasaki Y, Suzuki J, Nozawa R, Suzuki H. Efficacy of school urinary screening for membranoproliferative glomerulonephritis type I. Arch Dis Child 2002;86:21-5   DOI
21 Cattran DC, Cardella CJ, Roscoe JM, Charron RC, Rance PC, Ritchie SM, et al. Results of a controlled drug trial in membranoproliferative glomerulonephritis. Kidney Int 1985;27:436-41   DOI   ScienceOn
22 Iitaka K, Ishidate T, Hojo M, Kuwao S, Kasai N, Sakai T. Idiopathic membranoproliferative glomerulonephritis in Japanese children. Pediatr Nephrol 1995;9:272-7   DOI
23 Bahat E, Akkaya BK, Akman S, Karpuzoglu G, Guven AG. Comparison of pulse and oral steroid in childhood mem- branoproliferative glomerulonephritis. J Nephrol 2007;20:234-45
24 McEnergy PT, McAdams AJ, West CD. Membranoproliferative glomerulonephritis; improved survival with alternate day prednisone therapy. Clin Nephrol 1980;13:117-24